Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1

Neurofibromatosis type 1 (NF1) is a tumor predisposition syndrome caused by heterozygous NF1 gene mutations. Patients with NF1 present with pleiotropic somatic secondary manifestations, including development of bone pseudarthrosis after fracture. Somatic NF1 gene mutations were reproducibly identified in patient‐derived pseudarthrosis specimens, suggesting a local mosaic cell population including somatic pathologic cells. The somatic cellular pathogenesis of NF1 pseudarthroses remains unclear, though defects in osteogenesis have been posited. Here, we applied time‐series single‐cell RNA‐sequencing (scRNA‐seq) to patient‐matched control and pseudarthrosis‐derived primary bone stromal cells (BSCs). We show that osteogenic specification to an osteoblast progenitor cell population was evident for control bone‐derived cells and haploinsufficient pseudarthrosis‐derived cells. Similar results were observed for somatic patient fracture‐derived NF1 (−/−) cells; however, expression of genetic pathways associated with skeletal mineralization were significantly reduced in NF1 (−/−) cells compared with fracture‐derived NF1 (+/−) cells. In mice, we show that Nf1 expressed in bone marrow osteoprogenitors is required for the maintenance of the adult skeleton. Results from our study implicate impaired Clec11a‐Itga11‐Wnt signaling in the pathogenesis of NF1‐associated skeletal disease. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).